Literature DB >> 29104663

Effects of wogonin on the mechanism of melanin synthesis in A375 cells.

Xi Chen1, Ting Gu2, Jing-Hua Wang3, Hui Xiong2, Ye-Qiu Wang4, Guo-Liang Liu4, Yan Qu4, Ning Zhang4.   

Abstract

The present study aimed to investigate the effect of wogonin on the mechanism of melanin synthesis in the A375 melanoma cell line. A375 cells, cultured in vitro, were treated with wogonin and the activity of tyrosinase (TYR) and melanin synthesis were examined via MTT assay, L-dopa oxidation assay and an NaOH lysis assay. Protein expression levels of TYR and c-Jun N-terminal kinase (JNK) were examined via western blotting. mRNA expression levels of TYR, tyrosinase related protein (TRP)-1, TRP-2, extracellular signal-regulated kinase (ERK)-1, ERK-2 and JNK-2 were analyzed by reverse transcription-quantitative polymerase chain reaction. Furthermore, the effect of wogonin on estrogen receptor inhibitor (ICI182780) and ERK pathway inhibitor (U0126) was investigated. Safe doses of wogonin (10, 1, 10-1, 10-2 or 10-3 µmol/l) significantly inhibited melanin synthesis and TYR activity (P<0.05). Wogonin (10 µmol/l) inhibited the protein expression levels of TYR, JNK and mRNA expression levels of TYR, TRP-1, TRP-2, ERK-1, ERK-2, JNK-2 in A375 cells (P<0.01). The estrogen receptor inhibitor, ICI182780, and MEK inhibitor, U0126, significantly reversed the effects of wogonin on protein and mRNA expression levels of TYR, TRP-1, TRP-2, ERK-1, ERK-2 and JNK-2 (all P<0.01). To conclude, the present study identified that wogonin is able to inhibit the synthesis of melanin in A375 cells, through inhibiting protein and mRNA expression levels of TYR, TRP-1, and TRP-2, and ERK1, ERK2 and JNK2, respectively.

Entities:  

Keywords:  A375 cells; estrogen receptor-mitogen activated protein kinase; melanin; wogonin

Year:  2017        PMID: 29104663      PMCID: PMC5658711          DOI: 10.3892/etm.2017.5070

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  13 in total

1.  Treatment with Qing'E, a kidney-invigorating Chinese herbal formula, antagonizes the estrogen decline in ovariectomized mice.

Authors:  Ying Xu; Zi-Jia Zhang; Fang Geng; Shi-bing Su; Kenneth N White; S W Annie Bligh; Christopher J Branford-White; Zheng-tao Wang
Journal:  Rejuvenation Res       Date:  2010-08       Impact factor: 4.663

2.  Effects of betulinic acid alone and in combination with irradiation in human melanoma cells.

Authors:  E Selzer; E Pimentel; V Wacheck; W Schlegel; H Pehamberger; B Jansen; R Kodym
Journal:  J Invest Dermatol       Date:  2000-05       Impact factor: 8.551

Review 3.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

4.  Regulation of tyrosinase-related protein-2 (TYRP2) in human melanocytes: relationship to growth and morphology.

Authors:  D Fang; T Kute; V Setaluri
Journal:  Pigment Cell Res       Date:  2001-04

5.  Vascular relaxation induced by Eucommiae Ulmoides Oliv. and its compounds Oroxylin A and wogonin: implications on their cytoprotection action.

Authors:  Mary Akinyi; Xiu Mei Gao; Yu Hong Li; Bing Yao Wang; Er Wei Liu; Li Juan Chai; Abdulai JawoBah; Guan Wei Fan
Journal:  Int J Clin Exp Med       Date:  2014-10-15

6.  Terrein: a new melanogenesis inhibitor and its mechanism.

Authors:  S-H Park; D-S Kim; W-G Kim; I-J Ryoo; D-H Lee; C-H Huh; S-W Youn; I-D Yoo; K-C Park
Journal:  Cell Mol Life Sci       Date:  2004-11       Impact factor: 9.261

7.  Inhibition of MITF and tyrosinase by paeonol-stimulated JNK/SAPK to reduction of phosphorylated CREB.

Authors:  Jin Bu; Peng-Cheng Ma; Zhi-Qiang Chen; Wu-Qing Zhou; You-Jun Fu; Ling-Jun Li; Cheng-Rang Li
Journal:  Am J Chin Med       Date:  2008       Impact factor: 4.667

Review 8.  Selective estrogen receptor modulators: an update on recent clinical findings.

Authors:  Wendy Shelly; Michael W Draper; Venkatesh Krishnan; Mayme Wong; Robert B Jaffe
Journal:  Obstet Gynecol Surv       Date:  2008-03       Impact factor: 2.347

9.  Expression profiles of melanogenesis-related genes and proteins in acquired melanocytic nevus.

Authors:  Y Hashimoto; Y Ito; T Kato; T Motokawa; T Katagiri; M Itoh
Journal:  J Cutan Pathol       Date:  2006-03       Impact factor: 1.587

10.  Novel phytoandrogens and lipidic augmenters from Eucommia ulmoides.

Authors:  Victor Y C Ong; Benny K H Tan
Journal:  BMC Complement Altern Med       Date:  2007-01-29       Impact factor: 3.659

View more
  3 in total

1.  Anti-melanogenesis effect from Wampee fruit pectin via α-MSH/TRY pathway in A375 cells.

Authors:  Weiyu Fu; Xuehua Liao; Qian Zhang; Yuzhen Zhu; Si Mei; Qian Li; Xin Zhou; Xiaojun Li; Hui Luo; Hua Ye; Kefeng Wu
Journal:  BMC Complement Med Ther       Date:  2022-06-25

2.  Qingfei Jiedu decoction inhibits PD-L1 expression in lung adenocarcinoma based on network pharmacology analysis, molecular docking and experimental verification.

Authors:  Junjie Pan; Hongkuan Yang; Lihong Zhu; Yafang Lou; Bo Jin
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

Review 3.  The Interplay between Tumour Microenvironment Components in Malignant Melanoma.

Authors:  Cornelia Amalinei; Adriana Grigoraș; Ludmila Lozneanu; Irina-Draga Căruntu; Simona-Eliza Giușcă; Raluca Anca Balan
Journal:  Medicina (Kaunas)       Date:  2022-03-02       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.